“These 2 Penny Stocks Are Poised to Go Boom, Say Analysts”
December 31, 2020
“Matinas BioPharma (MTNB)…
Turning now to the rest of the Street, other analysts echo Hazlett’s sentiment. As only Buy recommendations have been published in the last three months, MTNB earns a Strong Buy analyst consensus. With the average price target clocking in at $4, shares could soar 359% from current levels…
Equillium (EQ)…
What does the rest of the Street have to say? 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. Given the $15 average price target, shares could skyrocket 328% in the year ahead…”
https://finance.yahoo.com/news/2-penny-stocks-poised-boom-162734377.html